Why the study?
To evaluate the feasibility and efficacy of predicting conduction system abnormalities using 3D electroanatomic mapping guidance during transcatheter closure of perimembranous ventricular septal defects in adults.
Does 3D electroanatomic mapping guidance predict procedure-related conduction block during transcatheter closure of perimembranous ventricular septal defects in adults?
Does 3D electroanatomic mapping guidance predict procedure-related conduction block during transcatheter closure of perimembranous ventricular septal defects in adults?
3D electroanatomic mapping can identify patients at high risk for conduction block during transcatheter closure of perimembranous VSDs by measuring the distance to the His-Purkinje system.
BACKGROUND: In this study we evaluated the feasibility and efficacy of predicting conduction system abnormalities under 3-dimensional (3D) electroanatomic mapping guidance during transcatheter closure of perimembranous ventricular septal defects (pmVSDs) in adults. METHODS AND RESULTS: The distribution of the His-Purkinje system (HPS) close to the margins of pmVSDs in the left ventricle was identified using 3D electroanatomic mapping and near-field HPS was further confirmed by different pacing protocols. Of the 20 patients in the study, 17 (85%) were successfully treated by transcatheter intervention. The minimum distance between the margins of the pmVSD and near-field HPS, as measured by 3D electroanatomic mapping, ranged from 1.3 to 3.9 mm (mean [± SD] 2.5±0.7 mm). Five patients with a minimum distance <2 mm had a higher risk (3/5; 60%) for adverse arrhythmic events, whereas patients with a distance >2 mm were at a much lower risk (1/15; 6.7%) of procedure-related conduction block (P=0.032). No other adverse events were recorded during the follow-up period (median 30 months). CONCLUSIONS: A minimum distance between the pmVSD and near-field HPS <2 mm was associated with a relatively high risk of closure-related conduction block. 3D electroanatomic mapping may be helpful in guiding decision making for transcatheter closure and reduce the incidence of adverse arrhythmic events.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: